Trial Profile
Phase I trial of tolterodine/pilocarpine once daily formulation [THVD-202] in women with overactive bladder and urge incontinence
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 04 Apr 2013
Price :
$35
*
At a glance
- Drugs Tolterodine/pilocarpine (Primary)
- Indications Overactive bladder; Urge incontinence
- Focus Adverse reactions
- 04 Apr 2013 New trial record